Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices.

Gopal Kumar PatidarKevin J LandHans VrielinkNaomi Rahimi-LeveneEldad J DannHind Al-HumaidanSteven L SpitalnikYashaswi Dhiman Cynthia So-Osman Salwa I Hindawi

Published in: Vox sanguinis (2021)

TPE in COVID-19 patients may help by removing toxic cytokines, viral particles and/or by correcting coagulopathy or restoring endothelial membrane. Severity score (SOFA & APACHE II) and cytokine levels (IL-6, C-reactive protein) can be used to execute TPE therapy and to monitor response in COVID-19 patients.

Keyphrases

sars cov
respiratory syndrome coronavirus
primary care
healthcare
endothelial cells
coronavirus disease
stem cells
cell therapy